Liothyronine Sodium

Liothyronine Sodium
Product Description

Liothyronine Sodium is indicated for the treatment of Patients with hypothyroidism of any etiology.

Biophore's Liothyronine Sodium: US DMF filed, Completeness Assessment done; CEP Filed


Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator
Specifications
  • Supplied from
    India
  • Measured In
    gram; kilogram

Biophore Pharma INC.

  • US
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Manufacturer/Innovator

More Products from Biophore Pharma INC. (57)

  • Temozolamide

    Product Temozolamide

    Temazolamide is used in the treatment of Anticancer.

    Biophore's Temozolamide: Polymorphic form; Form III, Stringent control on genotoxic impurities, Product meets USP specificationsm, All impurities below 0.15, DMF has been reviewed and approved in Europe, Particle size requirement as per c...
  • Zileuton

    Product Zileuton

    Zileuton is an NSAID, and  Anti Asthama agent.

    Biophore's Zileuton:   USFDA approved manufacturing facility, DMF Number 26446, Completeness Assessment of the US DMF Complete.
  • Diazoxide

    Product Diazoxide

    Diazoxide is an Anti hypoglycemic agent.


  • Eliglustat

    Product Eliglustat

    Eliglustat is an Endocrine-Metabolic Agent is indicated for the Long-term treatment of adult patients with Gaucher disease type 1.

    Biophore's Eliglustat: Under development



  • Gadobenate dimeglumine

    Product Gadobenate dimeglumine

    Gadobenate dimeglumine is an Diagnostic Agent which is indicated for the  treatment of Magnetic resonance imaging (MRI) of the central nervous system (CNS) in adults.


    Biophore's Gadobenate dimeglumine: API Developed, Stringent control on inorganic impurities, ...
  • Gadobutrol

    Product Gadobutrol

    Gadobutrol is an MRI Contrast Agent.

    Biophore's Gadobutrol:  Product meets the specifications of the EP draft monograph,  All impurities below 0.05, Stringent control on sodium and chloride. 
  • Methazolamide

    Product Methazolamide

    Methazolamide Anti Coagulant indicated for the treatment of ocular conditions.
    Biophore's Methazolamide: 
  • Nadolol

    Product Nadolol

    Nadolol is an Antihypertensive agent indicated for the treatment of long-term management of patients with angina pectoris.


    Biophore's Nadolol: Lab development complete. Tech pack available. Validations under progress. DMF by Q3, 2016.
  • Palbociclib

    Product Palbociclib

    Palbociclib is an Cyclin-Dependent Kinase Inhibitor indicated for the treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2. 

  • Sincalide

    Product Sincalide

    Sincalide is an Diagnostic Agent indicated To stimulate gallbladder, pancreatic secretion, to accelerate the transit of a barium meal through the small bowel.


    Biophore's Sincalide: API Developed, Validations Planned in Q3 2016, DMF to be filed in Q1 2017.
  • Zofenopril

    Product Zofenopril

    Zofenopril is an Antihypertensive agent.

    Biophore's Zofenopril: USFDA approved manufacturing facility, US DMF Filed  [ # 026446 ].
  • Tipiracil

    Product Tipiracil

    Tipiracil is an Thymidine  phosphorylase inhibitor/nucleoside metabolic inhibitor used to treatment of metastatic colorectal cancer.

Biophore Pharma INC. resources (1)